Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ATAGLU: Study of Glucose Metabolism in HIV Positive Patients That Switch From Another Protease Inhibitor to Boosted or Unboosted Atazanavir

NCT02102048 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT02102048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02102048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ATAGLU: Study of Glucose Metabolism in HIV Positive Patients That Switch From Another Protease Inhibitor to Boosted or Unboosted Atazanavir
Lead sponsor
University of Roma La Sapienza
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2009
Completion date
July 31, 2014
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv